European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 134, Issue 1 , Pages 20-23 , September 2007

Inherited thrombophilias and pre-eclampsia in Brazilian women

Received 29 November 2005 ,Revised 29 August 2006 ,Accepted 15 September 2006.

References 

  1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obst Gynecol 2000;183:S1–22.
  2. Sibai BM, Caritis SN, Thom E, et al. National Institute of Child Health and Human Development Network of Maternal–Fetal Medicine Units. Prevention of pre-eclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med. 1993;329:1213–1218
  3. Gilabert J, Estellés A, España F, Grancha S, Aznar J. Modifications de la hemostasia en obstetricia. Rev Iberoamer Tromb Hemostasia. 1995;8:102–112
  4. Estelles A, Gilabert J, Grancha S, et al. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe pre-eclampsia. Thromb Haemost. 1998;79:500–508
  5. Kobayashi T, Tokunaga N, Sugimura M, Kanayama N, Terao T. Predictive values of coagulation/fibrinolysis parameters for the termination of pregnancy complicated by severe pre-eclampsia. Semin Thromb Hemost. 2001;27(2):137–141
  6. Bertina RM, Factor V. Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem. 1997;43:1678–1683
  7. Poort SR, Rosendal FR, Reistma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698–3703
  8. D’angelo A, Selhub J. Homocysteine and thrombotic disease. Blood. 1997;90:1–11
  9. Agorastos T, Karavida A, Lambropoulos A, et al. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome. J Matern Fetal Neonatal Med. 2002;12(4):267–273
  10. Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A, Lessing JB. Severe pre-eclampsia and high frequency on genetic thrombophilic mutations. Obstet Ginecol. 2000;96:45–49
  11. De Groot CJM, loemenkamp KWM, Duvekot EI, et al. Pre-eclampsia and genetic risk factors for thrombosis: a case-control study. Am J Obstet Ginecol. 1999;181(40):975–980
  12. D’aniello G, Florio P, Sabatini I, et al. The search for thrombophilic gene mutations in women with gestational hypertension does not help in predicting poor pregnancy outcome. J Hypertens. 2003;21(10):1915–1920
  13. Fabbro D, D’elia AV, Spizzo R, et al. Association between plasminogen activator inhibitor 1 gene polymorphisms and pre-eclampsia. Gynecol Obstet Invest. 2003;56(1):17–22
  14. De Maat MPM, Jansen MWJC, Hille ETM, et al. Pre-eclampsia and its interaction with common variants in thrombophilia genes. J Thromb Haemost. 2004;2:1588–1593
  15. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SDJ. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci. 2003;100:177–182
  16. Frosst P, Blom HJ, Milos R, et al. A candidate risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Gen. 1995;10:111–113
  17. Huber S, McMmaster KJ, Voelkerding KV. Analytical evaluation of primer engineered multiplex polymerase chain reaction—restriction fragment length polymorphism for detection of Factor V Leiden and prothrombin G20210A. J Mol Diagn. 2000;2:153–157
  18. Dean AG, Dean JA. Coulombier, D. Epi Info, Version 6.04: a word processing database and statistics program for epidemiology on microcomputers. Atlanta: Centre of Disease Control and Prevention, 1997.
  19. Gerhardt A, Goecke TW, Beckmann MW, et al. The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe pre-eclampsia. J Thromb Haemost. 2004;3:686–691
  20. Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal Factor V Leiden genotype: a meta-analysis. Thromb Haemost. 2004;91(4):700–711
  21. Lin J, August P. Genetic thrombophilias and pre-eclampsia: a meta-analysis. Obstet Gynecol. 2005;105(1):182–192
  22. Mello G, Parretti E, Marozio L, et al. Thrombophilia is significantly associated with severe pre-eclampsia: results of a large-scale, case-controlled study. Hypertension. 2005;46(6):1270–1274
  23. Prasmusinto D, Skrablin S, Fimmers R, Van Der Ven K. Ethnic differences in the association of Factor V Leiden mutation and the C677T methylenetetrahydrofolate reductase gene polymorphism with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2004;112(2):162–169
  24. Arruda VR, Annichino-Bizzacchi JM, Costa FF, ReistmaF P.H. . Factor V Leiden (FVQ 506) is a common in a Brazilian population. A J Hematol. 1995;49:242–243
  25. Arruda VR, Annichino-Bizzacchi JM, Gonçalves MS, Costa FF. Prevalence of the prothrombin gene variant (G20210A) in venous thrombosis and arterial disease. Throm Haemost. 1997;78(6):1430–1433
  26. Arruda VR, Siqueira LH, Gonçalves MS, et al. Prevalence of mutation C677T in the methylene tetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet. 1998;78:332–335
  27. de Paula Sabino A, Ribeiro DD, Carvalho MG, Cardoso JE, Dusse LM, Fernandes AP. Factor V Leiden and increased risk for arterial thrombotic disease in young Brazilian patients. Blood Coagul Fibrinol. 2006;17(4):271–275
  28. Clarizia AD, Bastos-Rodrigues L, Pena HB, et al. Relationship of the methylenetetrahydrofolate reductase C677T polymorphism with microsatellite instability and promoter hypermethylation in sporadic colorectal cancer. Genet Mol Res. 2006;5(2):315–322
  29. Carod-Artal FJ, Nunes SV, Portugal D, Silva TV, Vargas AP. Ischemic stroke subtypes and thrombophilia in young and elderly Brazilian patients admitted to a rehabilitation hospital. Stroke. 2005;36(9):2012–2014
  30. Zanrosso CW, Hatagima A, Emereciano M, et al. The role of methylenetetrahydrofolate reductase in acute lymphoblastic leukemia in a Brazilian mixed population. Leukemia Res. 2006;30:477–481
  31. Pereira AC, Lourenço DM, Maffei FH, et al. A transcobalamin gene polymorphism and the risk of venous thrombosis. The BRATOS (Brazilian Thrombosis Study). Thrombosis Research, 2006.
  32. Pinto RB, Silveira RT, Bandinelli E, Röhsig L. Portal vein thrombosis in children and adolescents: the low prevalence of hereditary thrombophilic disorders. J Ped Surg. 2004;39(9):1356–1361
  33. Jaques PF, Bostom AG, Willians RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase and plasma homocysteine concentrations. Circulation. 1996;93:7–9
  34. Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of non-severe pre-eclampsia. Am J Obstet Gynecol. 2003;189(2):391–394
  35. Greer IA. Thrombophilia: implications for pregnancy outcome. Thromb Res. 2003;109(2–3):73–81

PII: S0301-2115(06)00510-0

doi: 10.1016/j.ejogrb.2006.09.006

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 134, Issue 1 , Pages 20-23 , September 2007

Article Tools

* Image Usage & Resolution